161 related articles for article (PubMed ID: 2438592)
41. Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia Nigra.
Haber SN; Groenewegen HJ
J Comp Neurol; 1989 Dec; 290(1):53-68. PubMed ID: 2480370
[TBL] [Abstract][Full Text] [Related]
42. Direct demonstration of interactions between substance P immunoreactive terminals and tyrosine hydroxylase immunoreactive neurons in the substantia nigra of the rat: an ultrastructural study.
Mahalik TJ
Synapse; 1988; 2(5):508-15. PubMed ID: 2460962
[TBL] [Abstract][Full Text] [Related]
43. Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts: an ultrastructural double-labeling immunocytochemical study.
Mendez I; Elisevich K; Flumerfelt B
J Comp Neurol; 1991 Jun; 308(1):66-78. PubMed ID: 1714923
[TBL] [Abstract][Full Text] [Related]
44. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
Hersch SM; Yi H; Heilman CJ; Edwards RH; Levey AI
J Comp Neurol; 1997 Nov; 388(2):211-27. PubMed ID: 9368838
[TBL] [Abstract][Full Text] [Related]
45. The nigrostriatal pathway in the rat: A single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome/matrix striatal compartments.
Prensa L; Parent A
J Neurosci; 2001 Sep; 21(18):7247-60. PubMed ID: 11549735
[TBL] [Abstract][Full Text] [Related]
46. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts.
Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ
Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221
[TBL] [Abstract][Full Text] [Related]
47. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.
Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B
Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609
[TBL] [Abstract][Full Text] [Related]
48. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
[TBL] [Abstract][Full Text] [Related]
49. Cholinergic stimulation of rostral and caudal substantia nigra pars compacta produces opposite effects on circling behavior and striatal dopamine release measured by brain microdialysis.
Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Rosales MG; Aceves J
Neuroscience; 1994 Sep; 62(2):441-7. PubMed ID: 7830890
[TBL] [Abstract][Full Text] [Related]
50. Single dopaminergic nigrostriatal neurons form two chemically distinct synaptic types: possible transmitter segregation within neurons.
Hattori T; Takada M; Moriizumi T; Van der Kooy D
J Comp Neurol; 1991 Jul; 309(3):391-401. PubMed ID: 1717519
[TBL] [Abstract][Full Text] [Related]
51. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
[TBL] [Abstract][Full Text] [Related]
52. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.
Savasta M; Dubois A; Scatton B
Brain Res; 1986 Jun; 375(2):291-301. PubMed ID: 2942221
[TBL] [Abstract][Full Text] [Related]
53. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
Frohna PA; Rothblat DS; Joyce JN; Schneider JS
Synapse; 1995 Jan; 19(1):46-55. PubMed ID: 7709343
[TBL] [Abstract][Full Text] [Related]
54. Conceptual history of the nigrostriatal dopamine system.
Hattori T
Neurosci Res; 1993 May; 16(4):239-62. PubMed ID: 8394552
[TBL] [Abstract][Full Text] [Related]
55. Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin.
Hery F; Soubrie P; Bourgoin S; Motastruc JL; Artaud F; Glowinski J
Brain Res; 1980 Jul; 193(1):143-51. PubMed ID: 6247027
[TBL] [Abstract][Full Text] [Related]
56. Loss of substance P and enkephalin immunoreactivity in the human substantia nigra after striato-pallidal infarction.
Pioro EP; Hughes JT; Cuello AC
Brain Res; 1984 Feb; 292(2):339-47. PubMed ID: 6198046
[TBL] [Abstract][Full Text] [Related]
57. Acute and repeated administration of fluphenazine-N-mustard alters levels of tyrosine hydroxylase mRNA in subsets of mesencephalic dopaminergic neurons.
Weiss-Wunder LT; Chesselet MF
Neuroscience; 1992 Jul; 49(2):297-305. PubMed ID: 1359452
[TBL] [Abstract][Full Text] [Related]
58. Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra.
Oblin A; Zivkovic B; Bartholini G
Brain Res; 1987 Sep; 421(1-2):387-90. PubMed ID: 2446703
[TBL] [Abstract][Full Text] [Related]
59. In vivo biosynthesis of [35S]- and [3H]substance P in the striatum of the rat and their axonal transport to the substantia nigra.
Krause JE; Reiner AJ; Advis JP; McKelvy JF
J Neurosci; 1984 Mar; 4(3):775-85. PubMed ID: 6200582
[TBL] [Abstract][Full Text] [Related]
60. Effects of unilateral electrical stimulation of various thalamic nuclei on the release of dopamine from dendrites and nerve terminals of neurons of the two nigrostriatal dopaminergic pathways.
Chéramy A; Chesselet MF; Romo R; Leviel V; Glowinski J
Neuroscience; 1983 Apr; 8(4):767-80. PubMed ID: 6866262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
